HGV 0.00% 5.1¢ hygrovest limited

Possibly.... SatiPharm, MMJ’s Swiss subsidiary has completed the...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 41 Posts.
    lightbulb Created with Sketch. 2
    Possibly....

    SatiPharm, MMJ’s Swiss subsidiary has completed the development of Sativol, a proprietary gastro-resistant Cannabidiol (CBD) pill that being launched in Europe as dietary supplement, with first revenues from pill sales anticipated from August 2015.
 
watchlist Created with Sketch. Add HGV (ASX) to my watchlist
(20min delay)
Last
5.1¢
Change
0.000(0.00%)
Mkt cap ! $10.72M
Open High Low Value Volume
5.1¢ 5.1¢ 5.1¢ $5.853K 114.7K

Buyers (Bids)

No. Vol. Price($)
2 166237 5.1¢
 

Sellers (Offers)

Price($) Vol. No.
5.2¢ 27000 1
View Market Depth
Last trade - 16.10pm 08/10/2024 (20 minute delay) ?
HGV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.